一种针对心脏的纳米酶在心肌梗塞中中断了无炎激素循环
Xueliang Liu1, Binghua Chen2, Jingqi Chen1
1Institute of Molecular Medicine (IMM), Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200240, China.
Advanced materials (Deerfield Beach, Fla.)
|November 20, 2023
概括
一种新的纳米酶疗法通过减少炎症和自由基来向心肌梗塞 (MI). 这种新的治疗方法增强了心脏保留率,保持了心脏功能,并在临床前模型中减少了痕大小.
科学领域:
- 生物材料科学 生物材料科学
- 纳米医学是一种纳米医学.
- 心血管研究研究心血管研究
背景情况:
- 心肌梗塞 (MI) 后的全身炎症显著增加了死亡率.
- 心脏病诱导的自由基会加剧心脏炎症,导致心力衰竭.
- 目前的抗炎药物由于心脏向不佳和效果较弱,效果有限.
研究的目的:
- 开发一种新的纳米酶,用于针对心肌梗塞的向治疗.
- 为了研究纳米酶的抗炎和自由基清除能力.
- 在临床前MI模型中评估纳米酶的治疗潜力.
主要方法:
- 通过协调Fe3+和黄素 (Cur) 与酸 (TA) 来制造Fe-Cur@TA纳米酶.
- 对纳米酶的抗炎作用的评估,包括免疫细胞透,巨细胞极化和细胞因子抑制.
- 使用体内模型评估心脏保留和吸收.
- 在小鼠和小猎犬MI模型中测试治疗疗效.
主要成果:
- Fe-Cur@TA纳米酶表现出强大的自由基清除和抗炎性质.
- 纳米酶有效地减少了免疫细胞的透,并促进了类似M2的巨细胞两极分化.
- 丹尼酸修饰显著增强了心脏保留和吸收 (几乎增加了十倍).
- 在体内研究显示,心脏功能得到维护,MI后痕大小减少.
结论:
- 在心脏病变中,Fe-Cur@TA纳米酶有效地阻断了无炎性基循环.
- 与未经修改的对应物相比,纳米酶表现出优越的心脏向和保留.
- 这种新型纳米酶疗法在治疗心肌梗塞和心血管疾病方面具有显著的临床转化前景.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
01:16Antianginal Drugs: Nitrates and β-Blockers
601
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
601
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
538
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
538